National Review op-ed: 8 questions from pro-lifers for Robert F. Kennedy Jr.
Caroline MolloyPresident-elect Donald Trump’s nomination of Robert F. Kennedy Jr. as Secretary of the Department of Health and Human Services (HHS) has raised concerns among pro-life advocates, prompting questions about whether he will commit to key pro-life policy priorities.
In an op-ed titled “Eight Questions for Robert F. Kennedy Jr.,” published in National Review, Michael J. New, a senior associate scholar at the Charlotte Lozier Institute, noted that while many pro-lifers supported Trump hoping he would appoint pro-life leaders to key positions, Kennedy has never identified as pro-life. To address these concerns, New outlined eight critical questions Kennedy should answer to reassure pro-life groups and senators.
>> WHAT RFK TOLD ME <<
New first highlighted the impact of FDA policies on chemical abortions, which he stated were a key factor in the rising U.S. abortion rate since 2017. He pointed out that in 2016, the FDA extended the allowable limit for chemical abortions from seven to 10 weeks and reduced required in-person visits from three to one without fully studying the public health consequences.
He asked, “As HHS Secretary, would you support revoking these policy changes?”
New also criticized the Biden administration for permitting the distribution of chemical abortion drugs by mail during the COVID-19 pandemic. He argued that this practice poses serious risks to women, especially those with ectopic pregnancies or advanced gestational stages.
